PT Bundamedik Tbk (BMHS.JK)
IDR 252.0
(0.8%)
IDR 252.0
(0.8%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1119.95 Billion IDR | 20.24% |
| 2022 | 931.41 Billion IDR | 39.81% |
| 2021 | 666.2 Billion IDR | -17.97% |
| 2020 | 812.15 Billion IDR | 56.76% |
| 2019 | 518.1 Billion IDR | -2.92% |
| 2018 | 533.65 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1230.01 Billion IDR | 6.49% |
| 2024 Q1 | 1155.08 Billion IDR | 3.14% |
| 2024 Q3 | 710.64 Billion IDR | 21.52% |
| 2023 Q2 | 967.35 Billion IDR | 1.93% |
| 2023 Q1 | 948.99 Billion IDR | 1.89% |
| 2023 FY | 1119.95 Billion IDR | 20.24% |
| 2023 Q4 | 1119.95 Billion IDR | 2.57% |
| 2023 Q3 | 1091.85 Billion IDR | 12.87% |
| 2022 Q2 | 886.35 Billion IDR | 6.8% |
| 2022 Q1 | 829.89 Billion IDR | 24.57% |
| 2022 FY | 931.41 Billion IDR | 39.81% |
| 2022 Q4 | 931.41 Billion IDR | 2.72% |
| 2022 Q3 | 906.71 Billion IDR | 2.3% |
| 2021 FY | 666.2 Billion IDR | -17.97% |
| 2021 Q4 | 666.2 Billion IDR | 29.58% |
| 2021 Q3 | 514.14 Billion IDR | -35.75% |
| 2021 Q2 | 800.2 Billion IDR | 0.0% |
| 2021 Q1 | - IDR | -100.0% |
| 2020 Q4 | 812.15 Billion IDR | 0.0% |
| 2020 FY | 812.15 Billion IDR | 56.76% |
| 2020 Q1 | - IDR | 0.0% |
| 2019 FY | 518.1 Billion IDR | -2.92% |
| 2018 FY | 533.65 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Metro Healthcare Indonesia Tbk | 954.51 Billion IDR | -17.332% |
| PT Medikaloka Hermina Tbk | 2260.89 Billion IDR | 50.464% |
| PT Mitra Keluarga Karyasehat Tbk | 3.05 Billion IDR | -36569.633% |
| PT Murni Sadar Tbk | 495.02 Billion IDR | -126.241% |
| PT Famon Awal Bros Sedaya Tbk | 1278.14 Billion IDR | 12.377% |
| PT Royal Prima Tbk | - IDR | -Infinity% |
| PT Kedoya Adyaraya Tbk | - IDR | -Infinity% |
| PT Sarana Meditama Metropolitan Tbk | 963.22 Billion IDR | -16.272% |
| PT Siloam International Hospitals Tbk | 647.1 Billion IDR | -73.07% |
| PT Sejahteraraya Anugrahjaya Tbk | 1650.23 Billion IDR | 32.134% |